These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23485655)

  • 41. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration.
    Jung JJ; Chen CY; Mrejen S; Gallego-Pinazo R; Xu L; Marsiglia M; Boddu S; Freund KB
    Am J Ophthalmol; 2014 Oct; 158(4):769-779.e2. PubMed ID: 25034111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of age-related macular degeneration on macular thickness measurement made with fourier-domain optical coherence tomography.
    Garas A; Papp A; Holló G
    J Glaucoma; 2013 Mar; 22(3):195-200. PubMed ID: 22314250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restoration of Outer Retinal Layers After Aflibercept Therapy in Exudative AMD: Prognostic Value.
    Coscas F; Coscas G; Lupidi M; Dirani A; Srour M; Semoun O; Français C; Souied EH
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4129-34. PubMed ID: 26114491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration at twenty-four months: the Pan-American Collaborative Retina Study.
    Arevalo JF; Sánchez JG; Wu L; Berrocal MH; Alezzandrini AA; Restrepo N; Maia M; Farah ME; Brito M; Díaz-Llopis M; Rodríguez FJ; Reategui G; Iturralde-Iraola J; Udaondo-Mirete P;
    Ophthalmology; 2010 Oct; 117(10):1974-81, 1981.e1. PubMed ID: 20569989
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity.
    Saito M; Iida T; Kano M
    Retina; 2012 Jul; 32(7):1250-9. PubMed ID: 22446886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-year results of visual outcome with disease activity-guided ranibizumab algorithm for the treatment of exudative age-related macular degeneration.
    Lala C; Framme C; Wolf-Schnurrbusch UE; Wolf S
    Acta Ophthalmol; 2013 Sep; 91(6):526-30. PubMed ID: 22697404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab.
    Cho H; Shah CP; Weber M; Heier JS
    Br J Ophthalmol; 2013 Aug; 97(8):1032-5. PubMed ID: 23766432
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion.
    Wolf-Schnurrbusch UE; Ghanem R; Rothenbuehler SP; Enzmann V; Framme C; Wolf S
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3334-7. PubMed ID: 21087958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration.
    Gomi F; Sawa M; Tsujikawa M; Nishida K
    Retina; 2012 Oct; 32(9):1804-10. PubMed ID: 22718152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of intravitreal bevacizumab (Avastin) in neovascular age-related macular degeneration using a treatment regimen based on optical coherence tomography: 6- and 12-month results.
    Leydolt C; Michels S; Prager F; Garhoefer G; Georgopoulos M; Polak K; Schmidt-Erfurth U
    Acta Ophthalmol; 2010 Aug; 88(5):594-600. PubMed ID: 19485959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections.
    Mekjavic PJ; Kraut A; Urbancic M; Lenassi E; Hawlina M
    Acta Ophthalmol; 2011 Nov; 89(7):647-53. PubMed ID: 19860774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Furino C; Boscia F; Recchimurzo N; Besozzi G; Cardascia N; Sborgia L; Niro A; Sborgia C
    Acta Ophthalmol; 2009 Jun; 87(4):404-7. PubMed ID: 18782335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The predictive value of subjective symptoms and clinical signs for the presence of treatment-requiring exudative age-related macular degeneration.
    Hessellund A; Larsen DA; Bek T
    Acta Ophthalmol; 2012 Aug; 90(5):471-5. PubMed ID: 21232080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Retina; 2013 May; 33(5):990-7. PubMed ID: 23446653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravitreal ranibizumab versus thermal laser photocoagulation in the treatment of extrafoveal classic choroidal neovascularization secondary to age-related macular degeneration.
    Ladas ID; Chatziralli IP; Kotsolis AI; Douvali M; Georgalas I; Theodossiadis PG; Rouvas AA
    Ophthalmologica; 2012; 228(2):93-101. PubMed ID: 22571933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of fixation in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab.
    Mathew R; Pearce E; Sivaprasad S
    Am J Ophthalmol; 2012 Mar; 153(3):490-496.e1. PubMed ID: 22071230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF SUBRETINAL FIBROSIS IN AGE-RELATED MACULAR DEGENERATION.
    Miere A; Semoun O; Cohen SY; El Ameen A; Srour M; Jung C; Oubraham H; Querques G; Souied EH
    Retina; 2015 Nov; 35(11):2275-84. PubMed ID: 26457397
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One year follow-up of functional recovery in neovascular AMD during monthly anti-VEGF treatment.
    Munk MR; Kiss C; Huf W; Sulzbacher F; Roberts P; Mittermüller TJ; Sacu S; Simader C; Schmidt-Erfurth U
    Am J Ophthalmol; 2013 Oct; 156(4):633-43. PubMed ID: 23891335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Foveal microstructure and visual acuity in surgically closed macular holes: spectral-domain optical coherence tomographic analysis.
    Wakabayashi T; Fujiwara M; Sakaguchi H; Kusaka S; Oshima Y
    Ophthalmology; 2010 Sep; 117(9):1815-24. PubMed ID: 20472291
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Causes of unsuccessful ranibizumab treatment in exudative age-related macular degeneration in clinical settings.
    Cohen SY; Oubraham H; Uzzan J; Dubois L; Tadayoni R
    Retina; 2012 Sep; 32(8):1480-5. PubMed ID: 22258164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.